CIP
TEVA icon

Cornerstone Investment Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Cornerstone Investment Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,000
Closed -$148K – 296
2021
Q2 		$148K Hold
15,000
– – 0.01% 287
2021
Q1 		$173K Hold
15,000
– – 0.01% 260
2020
Q4 		$145K Hold
15,000
– – 0.01% 198
2020
Q3 		$135K Hold
15,000
– – 0.01% 144
2020
Q2 		$185K Hold
15,000
– – 0.01% 134
2020
Q1 		$135K Hold
15,000
– – 0.01% 134
2019
Q4 		$147K Hold
15,000
– – 0.01% 196
2019
Q3 		$103K Hold
15,000
– – ﹤0.01% 92
2019
Q2 		$138K Hold
15,000
– – 0.01% 94
2019
Q1 		$235K Sell
15,000
-300
-2% -$5.29K 0.01% 84
2018
Q4 		$236K Hold
15,300
– – 0.01% 76
2018
Q3 		$330K Sell
15,300
-3,000
-16% -$69.6K 0.01% 77
2018
Q2 		$445K Buy
18,300
+3,000
+20% +$61.2K 0.02% 73
2018
Q1 		$261K Hold
15,300
– – 0.01% 87
2017
Q4 		$290K Hold
15,300
– – 0.01% 79
2017
Q3 		$269K Sell
15,300
-5,427
-26% -$122K 0.01% 80
2017
Q2 		$689K Hold
20,727
– – 0.03% 64
2017
Q1 		$665K Sell
20,727
-20,666
-50% -$705K 0.03% 65
2016
Q4 		$1.5M Buy
41,393
+5,912
+17% +$236K 0.06% 40
2016
Q3 		$1.63M Buy
35,481
+52
+0.1% +$2.71K 0.07% 40
2016
Q2 		$1.78M Sell
35,429
-834
-2% -$44.4K 0.06% 37
2016
Q1 		$1.94M Sell
36,263
-978
-3% -$57.4K 0.06% 44
2015
Q4 		$2.44M Sell
37,241
-3,300
-8% -$204K 0.08% 43
2015
Q3 		$2.29M Buy
40,541
+3,868
+11% +$251K 0.07% 42
2015
Q2 		$2.17M Sell
36,673
-3,110
-8% -$192K 0.05% 41
2015
Q1 		$2.48M Hold
39,783
– – 0.05% 41
2014
Q4 		$2.29M Sell
39,783
-5,192
-12% -$289K 0.03% 39
2014
Q3 		$2.42M Hold
44,975
– – 0.03% 38
2014
Q2 		$2.36M Hold
44,975
– – 0.03% 40
2014
Q1 		$2.38M Sell
44,975
-3,465
-7% -$160K 0.03% 38
2013
Q4 		$1.94M Sell
48,440
-190
-0.4% -$7.48K 0.02% 40
2013
Q3 		$1.84M Sell
48,630
-1,625
-3% -$63.4K 0.03% 37
2013
Q2 		$1.97M Buy
+50,255
New +$1.96M 0.03% 39

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cornerstone Investment Partners's TEVA Position: Q3 2021 in Review

Cornerstone Investment Partners sold out of Teva Pharmaceuticals (TEVA) in Q3 2021, closing a stake of 15,000 shares — an estimated $148K sold.

Cornerstone Investment Partners first reported a position in TEVA in Q2 2013 and held it in 33 quarters. The position peaked at $2.48M in Q1 2015. 429 funds tracked by Wall St. Rank hold TEVA as of Q3 2021.

  • Cornerstone Investment Partners reported no remaining Teva Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Cornerstone Investment Partners sold 15,000 Teva Pharmaceuticals shares in Q3 2021, an estimated $148K.
  • Cornerstone Investment Partners first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 33 quarters.
  • Cornerstone Investment Partners's Teva Pharmaceuticals position peaked at $2.48M in Q1 2015.
  • 429 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2021.

Based on Cornerstone Investment Partners's 13F filing for Q3 2021, filed 25 Oct 2021.